BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today
BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股市新聞、股票諮詢和交易提示
Shares of BIOLASE (NASDAQ:BIOL), a company that specializes in dental lasers, was up 20% in pre-market trading after it was granted a reprieve by the Nasdaq stock exchange.
的股份生物酶納斯達克：BIOL是一家專門從事牙科激光的公司，在獲得政府批准暫緩上市後，該公司在盤前交易中上漲了20%.納斯達克證券交易所。
At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news release, BIOLASE announced that it has been granted a 180-day extension to regain compliance with this requirement.
以每股47美分的價格出售的Biol股票面臨被納斯達克摘牌的危險，後者要求公司維持1美元的最低股價才能留在交易所。然而，在一份新聞稿中，BIOLASE宣佈它已獲準延期180天，以重新遵守這一要求。
What Happened With BIOL Stock
Biol Stock發生了什麼？
Nasdaq has told BIOLASE that it has until May 23, 2022 to get its share price above $1 and keep it there for a minimum of 10 consecutive trading days. If it can do that, it will regain compliance with the exchange and avoid being delisted. That extension buys BIOLASE some much-needed time to raise its stock from its current price.
納斯達克已經告訴Biolase，它必須在2022年5月23日之前讓股價升至更高水平$1並在那裏保持至少連續10個交易日。如果它能做到這一點，它將重新遵守交易所的規定，並避免被摘牌。這一延期為BIOLASE贏得了一些亟需的時間，以提高其股票在當前價格的基礎上。
Investors have welcomed the news, judging by the fact that BIOL stock shot up more than 20% before the opening bell. Although shares have cooled off slightly, they are still up 12% in morning trading.
投資者對這一消息表示歡迎，因為Biol的股價在開盤前飆升了20%以上。儘管股價略有降温，但在早盤交易中仍上漲了12%。
BIOL stock has been on a steady decline for several years now. A publicly traded company since 1992, its stock had been trading at just under $100 per share in 2004. However, since that peak, the share price has steadily eroded. In 2013, the shares were trading at $25 and they have slid lower and lower since.
Biol的庫存幾年來一直在穩步下降。該公司自1992年以來一直是一家上市公司，2004年的股價略低於每股100美元。然而，自那次峯值以來，股價一直在穩步下跌。2013年，該公司股價為25美元，此後不斷下滑。
Why It Matters
為什麼這很重要
The extension by Nasdaq removes some immediate uncertainty surrounding BIOL stock. It also gives the Foothill Ranch, California-based company time to improve its financials, gain the confidence of investors, and push its stock price above the $1 minimum needed to remain on the Nasdaq. It is a positive development for BIOLASE in the near term.
納斯達克的延期消除了圍繞生物股票的一些迫在眉睫的不確定性。這也給了這家總部位於加利福尼亞州山麓牧場的公司時間來改善其財務狀況，贏得投資者的信心，並將其股價推高至1美元以上，這是留在納斯達克所需的最低價格。這在短期內對BIOLASE來説是一個積極的發展。
However, the 180-day extension by Nasdaq does not remove the longer-term issues facing the dental company or change the fact that its shares have collapsed over the last 15 years. Should BIOLASE fail to get its share price above $1 between now and May, it will be removed from the Nasdaq and likely end up trading on the over-the-counter market, also known as the pink sheets.
然而，納斯達克的180天延期並沒有消除這家牙科公司面臨的長期問題，也沒有改變其股價在過去15年裏暴跌的事實。如果從現在到5月，Biolase的股價未能超過1美元，它將被從納斯達克中除名，很可能最終在場外交易市場(也被稱為粉單)進行交易。
Trading on the over-the-counter market could impact BIOL stock's liquidity, access to capital, and the ability of investors to access the company's shares.
在場外交易市場上的交易可能會影響Biol股票的流動性、獲得資本的渠道以及投資者獲得該公司股票的能力。
What's Next for BIOLASE
BIOLASE的下一步是什麼
Today's gains are a step in the right direction for BIOL stock. But this doesn't solve the need for BIOLASE to get its share price up above $1 and keep it there for 10 consecutive days.
今天的漲幅是Biol股票朝着正確方向邁出的一步。但這並不能解決BIOLASE股價升至1美元上方並連續10天保持在這一水平的需要。
The Nasdaq extension buys the company some sorely needed time, but BIOLASE will need to use that time to come up with a plan to right its ship and get its shares moving in the right direction.
納斯達克的延期為該公司贏得了一些亟需的時間，但Biolase需要利用這些時間拿出一個計劃，讓它重整旗鼓，讓它的股票朝着正確的方向前進。
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That's because these "penny stocks" are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com's writers disclose this fact and warn readers of the risks.
關於細價股和低成交量股票： 除了極少數例外，不會發布關於市值低於1億美元或每天交易量低於100,000股的公司的評論。這是因為這些“廉價股”經常是詐騙藝術家和市場操縱者的遊樂場。如果我們確實發佈了可能受我們的評論影響的低成交量股票的評論，我們要求 InvestorPlace.com該書的作者披露了這一事實，並警告讀者其中的風險。
Read More: Penny Stocks — How to Profit Without Getting Scammed
更多閲讀： 便士股票-如何在不上當的情況下獲利
On the date of publication, Joel Baglole did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版之日，喬爾·巴格洛(Joel Baglole)沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點，以InvestorPlace.com發佈指南為準.
The post BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today appeared first on InvestorPlace.
Bio Stock Alert的帖子：鮮為人知的BIOLASE今天為何飆升--首先出現在InvestorPlace上。